JPMORGAN CHASE & CO - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$36,372,000
+1319.1%
1,058,899
+590.1%
0.01%
Q2 2020$2,563,000
+72.1%
153,433
+48.5%
0.00%
Q1 2020$1,489,000
-62.5%
103,289
-13.0%
0.00%
-100.0%
Q4 2019$3,972,000
+47.3%
118,700
-7.8%
0.00%0.0%
Q3 2019$2,696,000
+11.0%
128,715
+5.6%
0.00%
Q2 2019$2,429,000
-15.5%
121,928
-5.2%
0.00%
-100.0%
Q1 2019$2,876,000
-17.4%
128,634
-11.6%
0.00%0.0%
Q4 2018$3,482,000
-12.6%
145,586
-0.3%
0.00%0.0%
Q3 2018$3,982,000
+8.4%
145,966
+6.8%
0.00%0.0%
Q2 2018$3,675,000
-19.1%
136,677
-4.3%
0.00%0.0%
Q1 2018$4,544,000
-25.7%
142,751
-11.7%
0.00%0.0%
Q4 2017$6,112,000
-15.6%
161,609
-45.1%
0.00%
-50.0%
Q3 2017$7,240,000
+2.7%
294,405
-14.1%
0.00%0.0%
Q2 2017$7,047,000
+23.0%
342,757
+30.1%
0.00%
+100.0%
Q1 2017$5,727,000
-5.4%
263,532
-11.0%
0.00%0.0%
Q4 2016$6,057,000
+121.1%
296,187
+62.2%
0.00%0.0%
Q3 2016$2,740,000
+138.9%
182,650
+72.4%
0.00%
Q2 2016$1,147,000
+99.8%
105,975
+150.5%
0.00%
Q1 2016$574,00042,3000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders